2019
REPRODUCIBILITY AND OPTIMIZATION OF 18-FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR EVALUATION OF CARDIAC SARCOIDOSIS
Alvi R, Young B, Shahab Z, Pan H, Winkler J, Herzog E, Miller E. REPRODUCIBILITY AND OPTIMIZATION OF 18-FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR EVALUATION OF CARDIAC SARCOIDOSIS. Journal Of The American College Of Cardiology 2019, 73: 1659. DOI: 10.1016/s0735-1097(19)32265-x.Peer-Reviewed Original Research
2018
Specific Pro-Inflammatory Signaling Pathways are Induced in Patients with Cardiac Sarcoidosis; Potential Prognostic/Therapeutic Applications
Young B, Oatmen K, Freeburg L, Zellars K, Sapp A, Herzog E, Miller E, Spinale F. Specific Pro-Inflammatory Signaling Pathways are Induced in Patients with Cardiac Sarcoidosis; Potential Prognostic/Therapeutic Applications. Journal Of Cardiac Failure 2018, 24: s10. DOI: 10.1016/j.cardfail.2018.07.033.Peer-Reviewed Original ResearchCardiac sarcoidosisCardiac inflammationSarcoid patientsReceptor levelsEpidermal growth factorNormal subjectsSoluble tumor necrosis factor receptor IITumor necrosis factor receptor IIFluorodeoxyglucose positron emission tomographyPro-inflammatory signaling pathwaysAnti-inflammatory regimensMethods Plasma samplesHeart failure therapySoluble receptor levelsSpecific inflammatory pathwaysSpecific therapeutic targetingInflammatory signaling cascadesSpecific therapeutic targetsPositron emission tomographyCytokine receptor profilesCardiac involvementFailure therapyPrognostic valueTreatment regimensInflammatory pathways